Project Grant HT94252510411
Award Date
9/30/25
Completion Date
9/29/29
Dollars Obligated
$5.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
The University of Virginia (UVA) received a $847,875 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, effective September 1, 2025 through August 31, 2028, will support research targeting Schwann cell-tumor microenvironment interactions in neurofibroma development. The federal grant funding will enable UVA to conduct advanced biomedical research aimed at transforming healthcare for military service members,...
The University of Virginia was awarded a $2,728,777 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on May 1, 2025, will support advanced biomedical research on "Neuroactive Steroid Biosynthesis and Dynamic GABAA Receptor Reconfiguration in Postpartum Depression" over a performance period ending on April 30, 2029. This research aims to transform healthcare for military service...
This federal Project Grant award of $1,592,860.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The award was granted to the Rector & Visitors of the University of Virginia, a prominent academic research institution, to conduct ultrasensitive proteomics research for type 1 diabetes prediction and treatment efficacy...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $3,208,546.00 to the Rector & Visitors of the University of Virginia (UVA) to expand the Generalized Blast Exposure Value Tool. The goal is to determine cumulative blast exposure thresholds in military populations. The award period runs from May 15, 2025 to May 14, 2029. UVA, a prominent academic research institution, will leverage its expertise across...
The Department of Defense's Defense Health Agency awarded Virginia Commonwealth University (VCU) a $568,461 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "READING HISTONE H2A UBIQUITINATION IN THE FUNCTION OF RSF1 IN BREAST CANCERS WITH RSF1 GENE AMPLIFICATION." The grant, effective from March 1, 2024 through February 28, 2027, will fund VCU's research to advance the scientific understanding of breast cancer and develop...
The Department of Defense's Defense Health Agency awarded a $1,836,611 Project Grant to Virginia Commonwealth University (VCU) under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 1, 2025, supports advanced biomedical research to develop a novel cell therapy for the treatment of advanced prostate cancer. VCU, a public research university in Richmond, Virginia, has demonstrated extensive capabilities in scientific research and technical...
This $693,642 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports research at the University of Virginia to enhance vaccine-induced tumor-infiltrating lymphocytes (VITILS) in melanoma. The 3-year research project aims to develop innovative approaches to boost the effectiveness of cancer immunotherapies by improving the ability of T cells to infiltrate and attack melanoma tumors. Key deliverables will include...
The Defense Health Agency awarded a $3,995,791 project grant to Virginia Commonwealth University under the Military Medical Research and Development program (CFDA 12.420) to compare the attentional demands and functional outcomes of pattern recognition and direct myoelectric control in people with transradial amputation. VCU will conduct this research from September 2023 through September 2027 in Richmond, Virginia. Two subawards were also provided. Hanger Institute for Clinical Research and...
The University of Virginia will receive $748,422 under a three-year Project Grant award from the Department of the Army Medical Command. The award is funded through the Military Medical Research and Development program (CFDA 12.420). The University will quantify the relationship between brain biomechanics and head exposures relevant to warfighters. Insights gained from this research aim to guide the development of future injury prevention technologies. Specifically, the University seeks to...
The Defense Health Agency awarded a $724,500 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Duke University. The grant, titled "Targeting Dormancy-Associated Immune Tolerance to Eliminate Residual Breast Cancer," will fund advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The research, to be conducted at Duke University's Office of Research Administration Division from March...